Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) vs Vaxxinity, Inc. (VAXX)

Chemomab Therapeutics Ltd. Sponsored ADR and Vaxxinity, Inc. are both Biotechnology companies. Chemomab Therapeutics Ltd. Sponsored ADR and Vaxxinity, Inc. are of similar size ($16.0M and $15.5M). Across the 9 metrics below, Chemomab Therapeutics Ltd. Sponsored ADR leads on 5 and Vaxxinity, Inc. on 4.

Valuation

Metric CMMB VAXX Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 1.99 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.30 0.74
EV/Sales n/m (94.20) 10.73
Earnings yield (37.06%) 0.00% (28.84%)
Free cash flow yield (210.63%) 0.00% (23.03%)

Profitability

Metric CMMB VAXX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (82.17%) (150.65%) (57.72%)
Return on assets (70.70%) (75.55%) (49.22%)
Return on invested capital (247.40%) 0.00% 0.00%

Growth

Metric CMMB VAXX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 58.14% 25.00% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CMMB VAXX Biotechnology median
Debt to equity 0.00 0.99 0.00
Current ratio 6.41 1.89 4.73
Net debt to EBITDA 1.09 0.30 0.96

Dividend

Metric CMMB VAXX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CMMB VAXX Biotechnology median
Market cap 15.95m 15.47m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack